0001521536-13-000352.txt : 20130422 0001521536-13-000352.hdr.sgml : 20130422 20130419174644 ACCESSION NUMBER: 0001521536-13-000352 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20130422 DATE AS OF CHANGE: 20130419 EFFECTIVENESS DATE: 20130422 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIOZONE PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001412486 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 205978559 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-195303 FILM NUMBER: 13772413 BUSINESS ADDRESS: STREET 1: 550 SYLVAN AVENUE, SUITE 101 CITY: ENGLEWOOD CLIFFS STATE: NJ ZIP: 07632 BUSINESS PHONE: 201-608-5101 MAIL ADDRESS: STREET 1: 550 SYLVAN AVENUE, SUITE 101 CITY: ENGLEWOOD CLIFFS STATE: NJ ZIP: 07632 FORMER COMPANY: FORMER CONFORMED NAME: International Surf Resorts, Inc. DATE OF NAME CHANGE: 20070917 D 1 primary_doc.xml X0706 D LIVE 0001412486 BIOZONE PHARMACEUTICALS, INC. 550 SYLVAN AVENUE, SUITE 101 ENGLEWOOD CLIFFS NJ NEW JERSEY 07632 (201) 608-5101 NEVADA International Surf Resorts Inc. International Surf Resorts, Inc. Corporation true Elliot M. Maza 550 SYLVAN AVENUE, SUITE 101 ENGLEWOOD CLIFFS NJ NEW JERSEY 07632 Executive Officer Director Chief Executive Officer, Chief Financial Officer and Secretary Roberto Prego-Novo 550 SYLVAN AVENUE, SUITE 101 ENGLEWOOD CLIFFS NJ NEW JERSEY 07632 Director Chairman Brian Keller 550 SYLVAN AVENUE, SUITE 101 ENGLEWOOD CLIFFS NJ NEW JERSEY 07632 Executive Officer Director President and Chief Scientific Officer Christian Oertle 550 SYLVAN AVENUE, SUITE 101 ENGLEWOOD CLIFFS NJ NEW JERSEY 07632 Executive Officer Chief Strategy Officer Other Decline to Disclose 06 false 2013-04-12 false true true false 0 Palladium Capital Advisors, LLC 129400 None None 230 PARK AVENUE, SUITE 539 NEW YORK NY NEW YORK 10169 FL FLORIDA IL ILLINOIS NY NEW YORK TX TEXAS false Indefinite 800000 Indefinite false 5 26500 0 Also issued, as sales compensation, warrants to purchase 16,000 shares of the Issuer's common stock at $0.50 per share. 0 false BIOZONE PHARMACEUTICALS, INC. /s/ Elliot Maza Elliot Maza Chief Executive Officer 2013-04-19